Evolent Health, Inc. (EVH) stock
Close on Nov 11, 2026Market cap $564.17MP/E –Yield –
Evolent Health, Inc. grew revenue 14.1% to $2.34B over the twelve months to Sep 30, 2026. At the latest close the market valued the company at $564.17M.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026
Valuation
- Market cap
- $564.17M
- P/E ratio
- –
- Price to sales
- 0.24
- Price to book
- 1.51
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $2.34B
- Net income
- -$507.69M
- EPS, diluted
- -$4.54
- Book value per share
- $3.30
- Diluted shares
- 113M
Trading
- Next earnings
- Feb 23, 2027 (estimated, during market hours)
- Previous close
- $4.80
- Open
- $4.78
- Day's range
- $4.77 – $5.00
- Volume
- 2,204,827
- Average volume (20 days)
- 1,859,569
- Index membership
- Russell 2000, Russell 3000
- Beta (5 years)
- 0.82
- 52-week range
- $2.10 – $6.25
- RSI (14 days)
- 62.4
- Volatility (1 year)
- 79.3%
- Relative volume
- 0.83×
- WACC
- 6.9%
Index membership is inferred from the holdings of funds that track each index (IWM, IWV), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.
Market cap history
Month-end market cap since 2015, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | EVH | S&P 500 | Difference | EVH per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +23.5% | -2.4% | +25.9 pts | ||
| 3 months | +21.7% | -1.2% | +22.9 pts | ||
| Year to date | +24.8% | +12.3% | +12.5 pts | ||
| 1 year | -1.0% | +12.4% | −13.4 pts | ||
| 3 years | -82.2% | +78.8% | −161.0 pts | -43.7% | +21.4% |
| 5 years | -82.6% | +75.2% | −157.8 pts | -29.5% | +11.9% |
| 10 years | -70.8% | +311.1% | −381.9 pts | -11.6% | +15.2% |
Fourteen years at a glance
Fiscal years 2012 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Evolent Health filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Results
- Results
- Update
About Evolent Health
Services-Management Services
Evolent coordinates healthcare for individuals with complex conditions, including cardiovascular disease, cancer, and musculoskeletal disorders. The company operates through a single reportable segment and delivers two primary offerings: specialty care management services and administrative services. Its specialty care management platform assists in clinical decision-making, establishes provider networks, and develops evidence-based treatment pathways. Its administrative services provide health plan operations, risk management, pharmacy benefit management, and analytics supported by its proprietary technology platform. Evolent serves healthcare payers, health plans, and risk-bearing entities, while supporting affiliated medical providers who deliver patient care.
Company profile, executives and historyEvolent Health stock: common questions
What is Evolent Health's stock price?
EVH closed at $4.99 on Nov 11, 2026, up 3.96% on the day. Over the past 52 weeks it traded between $2.10 and $6.25.
What is Evolent Health's market cap?
Evolent Health was worth $564.17M at the close on Nov 11, 2026: the share price times the diluted shares outstanding.
What is EVH's P/E ratio?
Evolent Health lost money over the twelve months to Sep 30, 2026 (diluted EPS -$4.54), so it has no meaningful P/E ratio.
How much revenue does Evolent Health make?
Evolent Health reported revenue of $2.34B for the twelve months to Sep 30, 2026, up 14.1% from a year earlier.
Does Evolent Health pay a dividend?
No. Evolent Health has not paid a cash dividend over the last twelve months.
When does Evolent Health report earnings next?
Evolent Health is expected to report Q4 FY2026 results on Feb 23, 2027, during market hours. The date is estimated from its past reporting pattern until the company confirms it.
How has EVH stock performed over the past year?
Including dividends, EVH returned -1.0% over the past year, against +12.4% for the S&P 500.
How many EVH shares are sold short?
11M shares were sold short at the latest FINRA report, 9.70% of the float, or 7.0 days of average trading volume.
Who are Evolent Health's competitors?
Companies most similar to Evolent Health by business, industry and size include ASTH, HURN, RTO, ICFI, IT.
See a number that looks wrong?